Re-induction with ipilimumab, gp100 peptide vaccine, or a combination of both from a phase III, randomized, double-blind, multicenter study of previously treated patients with unresectable stage III or IV melanoma Meeting Abstract
| Authors: | Hodi, F. S.; O'Day, S.; McDermott, D. F.; Haanen, J. B.; Robert, C.; Zhu, X.; Yellin, M. J.; Ibrahim, R. A.; Hoos, A.; Wolchok, J. D. |
| Abstract Title: | Re-induction with ipilimumab, gp100 peptide vaccine, or a combination of both from a phase III, randomized, double-blind, multicenter study of previously treated patients with unresectable stage III or IV melanoma |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-05-20 |
| Start Page: | 613s |
| Language: | English |
| ACCESSION: | WOS:000208852005180 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2010.28.15_suppl.8509 |
| Notes: | Meeting Abstract:8509 -- Source: Wos |
